Fresenius SE Cash on Hand 2016-2024 | FSNUY

Fresenius SE cash on hand from 2016 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Fresenius SE cash on hand for the quarter ending June 30, 2024 was $2.862B, a 6.24% increase year-over-year.
  • Fresenius SE cash on hand for 2023 was $2.773B, a 4.26% decline from 2022.
  • Fresenius SE cash on hand for 2022 was $2.896B, a 11.43% decline from 2021.
  • Fresenius SE cash on hand for 2021 was $3.27B, a 55.84% increase from 2020.
Fresenius SE Annual Cash on Hand
(Millions of US $)
2023 $2,773
2022 $2,896
2021 $3,270
2020 $2,098
2019 $1,852
2018 $3,199
2017 $1,849
2016 $1,747
2015 $1,159
Fresenius SE Quarterly Cash on Hand
(Millions of US $)
2024-06-30 $2,862
2024-03-31 $1,106
2023-12-31 $2,773
2023-09-30 $1,192
2023-06-30 $2,694
2023-03-31 $2,491
2022-12-31 $2,896
2022-09-30 $2,143
2022-06-30 $2,266
2022-03-31 $2,331
2021-12-31 $3,270
2021-09-30 $2,845
2021-06-30 $2,711
2021-03-31 $2,263
2020-12-31 $2,098
2020-09-30 $3,107
2020-06-30 $3,384
2020-03-31 $2,237
2019-12-31 $1,852
2019-09-30 $1,778
2019-06-30 $1,644
2019-03-31 $1,753
2018-12-31 $3,199
2018-09-30 $2,856
2018-06-30 $2,704
2018-03-31 $1,824
2017-12-31 $1,849
2017-09-30 $1,730
2017-06-30 $1,508
2017-03-31 $1,577
2016-12-31 $1,747
2016-09-30 $1,311
2016-06-30 $1,240
2016-03-31 $973
2015-12-31 $1,159
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $20.921B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $17.320B 17.55
DaVita (DVA) United States $12.060B 15.60
Encompass Health (EHC) United States $10.267B 24.21
Chemed (CHE) United States $8.277B 25.44
Elanco Animal Health (ELAN) United States $6.357B 14.29
RadNet (RDNT) United States $5.166B 122.54
Option Care Health (OPCH) United States $3.999B 18.95
Amedisys (AMED) United States $3.199B 22.78
Astrana Health (ASTH) United States $2.920B 41.31
LifeStance Health (LFST) United States $2.728B 0.00
Addus HomeCare (ADUS) United States $2.375B 27.86
U.S Physical Therapy (USPH) United States $1.464B 38.53
Pennant (PNTG) United States $1.004B 46.00
Aveanna Healthcare Holdings (AVAH) United States $0.929B 0.00
Atai Life Sciences (ATAI) Germany $0.198B 0.00
Daxor (DXR) United States $0.047B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.013B 0.00
Ontrak (OTRK) United States $0.007B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00